Adelaide Research & Scholarship: Search

Search

Results 1-10 of 31 (Search time: 0.004 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2003	MJA Practice Essentials - 2: Recent advances in therapy of diabetes - Endocrinology	Couper, J.; Prins, J.
	2006	A pilot study of SRL 172 (killed Mycobacterium vaccae) in healthy chronic hepatitis B carriers and hepatitis B vaccine non-responders	Goldwater, P.
	2009	ASPREN surveillance system for influenza-like illness: a comparison with FluTracking and the National Notifiable Diseases Surveillance System	Parrella, A.; Dalton, C.B.; Pearce, R.; Litt, J.C.B.; Stocks, N.
	1997	Randomized, comparative trial of 20 micrograms vs 40 micrograms Engerix B vaccine in hepatitis B vaccine non-responders	Goldwater, P.
	2002	Risk of death among cases attending South Australian major trauma services after severe trauma: the first 4 years of operation of a state trauma system	Brennan, P.; Everest, E.; Griggs, W.; Slater, A.; Carter, L.; Lee, C.; Semmens, J.; Wood, D.; Nguyen, A.; Owen, D.; Pilkington, P.; Roder, D.; Somers, R.
	2012	Induction of labor versus expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks: a randomized controlled trial	van der Ham, D.; Vijgen, S.; Nijhuis, J.; van Beek, J.; Opmeer, B.; Mulder, A.; Moonen, R.; Groenewout, M.; van Pampus, M.; Mantel, G.; Bloemenkamp, K.; van Wijngaarden, W.; Sikkema, M.; Haak, M.; Pernet, P.; Porath, M.; Molkenboer, J.; Kuppens, S.; Kwee, A.; Kars, M.; et al.; Middleton, P.
	2005	Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)	Swiedler, S.; Beck, M.; Bajbouj, M.; Giugliani, R.; Schwartz, I.; Harmatz, P.; Wraith, J.; Roberts, J.; Ketteridge, D.; Hopwood, J.; Guffon, N.; Miranda, C.; Teles, E.; Berger, K.; Piscia-Nichols, C.
	2016	Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID	van Bon, B.W.M.; Coe, B.P.; Bernier, R.; Green, C.; Gerdts, J.; Witherspoon, K.; Kleefstra, T.; Willemsen, M.H.; Kumar, R.; Bosco, P.; Fichera, M.; Li, D.; Amaral, D.; Cristofoli, F.; Peeters, H.; Haan, E.; Romano, C.; Mefford, H.C.; Scheffer, I.; Gecz, J.; et al.
	2018	A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk	Redondo, M.J.; Geyer, S.; Steck, A.K.; Sharp, S.; Wentworth, J.M.; Weedon, M.N.; Antinozzi, P.; Sosenko, J.; Atkinson, M.; Pugliese, A.; Oram, R.A.; Type 1 Diabetes TrialNet Study Group,
	1998	IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes	Couper, J.; Harrison, L.; Aldis, J.; Colman, P.; Honeyman, M.; Ferrante, A.